Tumor-infiltrating lymphocytes in melanoma
S Lee, K Margolin - Current oncology reports, 2012 - Springer
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
Tumor-Infiltrating Lymphocytes in Melanoma
S Lee, K Margolin - Current Oncology Reports, 2012 - infona.pl
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
[引用][C] Tumor-Infiltrating Lymphocytes in Melanoma
S Lee, K Margolin - Current Oncology Reports, 2012 - cir.nii.ac.jp
Tumor-Infiltrating Lymphocytes in Melanoma | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
Tumor-infiltrating lymphocytes in melanoma
S Lee, K Margolin - Current Oncology Reports, 2012 - providence.elsevierpure.com
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
Tumor-infiltrating lymphocytes in melanoma.
S Lee, K Margolin - Current Oncology Reports, 2012 - europepmc.org
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
[HTML][HTML] Tumor-infiltrating lymphocytes in melanoma
S Lee, K Margolin - Current oncology reports, 2012 - ncbi.nlm.nih.gov
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
Tumor-infiltrating lymphocytes in melanoma
S Lee, K Margolin - Current oncology reports, 2012 - pubmed.ncbi.nlm.nih.gov
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
Tumor-infiltrating lymphocytes in melanoma.
S Lee, K Margolin - Current Oncology Reports, 2012 - europepmc.org
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …